LILLY ENDOWMENT INC (auto-surfaced)
Tier None · cloneable
· 31-DEC-2025 → 31-MAR-2026
AUM $84,524,083,455 · 1 positions · top-10 100.0%
· SEC filing history →
13FScore 90/100 — cloning their disclosed top holdings over ~4.6y returned +38%/yr vs S&P +11%/yr (alpha +27%/yr), ahead of the market in 53% of quarters. Cloneable 13F equity book only — excludes hedges/shorts/non-US.
New positions
| Issuer | % book | Value | Conviction | Business |
|---|
| none |
Added to (≥+25% shares)
| Issuer | % book | Δ shares | Conviction | Business |
|---|
| none |
Top holdings now
| Issuer | % book | Business |
|---|
| $LLY · Eli Lilly and Company | 100.0% | Pharmaceutical company (diabetes, obesity) |